METASTATIC ADENOCARCINOMA OF THE PANCREAS
Clinical trials for METASTATIC ADENOCARCINOMA OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ADENOCARCINOMA OF THE PANCREAS trials appear
Sign up with your email to follow new studies for METASTATIC ADENOCARCINOMA OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets tough pancreatic cancer
Disease control TerminatedThis study tests a new drug called ABTL0812 added to standard chemotherapy (gemcitabine and nab-paclitaxel) for people with advanced pancreatic cancer that has spread. The goal is to see if the combination is safe and works better than chemo alone. The trial was suspended, so res…
Matched conditions: METASTATIC ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE1, PHASE2 • Sponsor: Ability Pharmaceuticals SL • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a special PET scan unlock a new way to treat Hard-to-Treat upper GI cancers?
Knowledge-focused OngoingThis study is testing whether a special PET scan using a tracer called 68Ga-PSMA can identify patients with advanced upper digestive tract cancers (like stomach or esophageal cancer) who might be eligible for a type of targeted radiation therapy called endoradiotherapy. The resea…
Matched conditions: METASTATIC ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE2 • Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC